His lab is focusing on refining the alanine-scanning assay to a couple critical residues which can correctly distinguish in between fibrils from neurodegenerative tauopathies. He envisions applying this streamlined assay for postmortem neuropathological analysis, And maybe for blood screening of tauopathies.Initially, they tested this technique on